Open Access<p>Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis</p>
Author(s) -
Borja de la Sen-Corcuera,
Jesús Montero-Iruzubieta,
Ronald Mauricio Sánchez-Ávila,
Gorka Orive,
Eduardo Anitua,
Manuel Caro-Magdaleno,
Jesús Merayo-Llovés
Publication year - 2020
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s252253
Subject(s) - medicine , ophthalmology , visual acuity , inflammation , surgery
The objective was to evaluate the clinical results obtained from the use of immunosafe plasma rich in growth factors (isPRGF) in the treatment of patients with cicatrizing conjunctivitis (CC) who had not responded to the usual therapy.